Labcorp Finalizes Acquisition of Select Assets of Invitae

Extends Labcorp’s leadership in genetic testing solutions for oncology and select rare diseases BURLINGTON, N.C., Aug. 5, 2024 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the completion of its acquisition of…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.